{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T21:03:56Z","timestamp":1765487036261,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Extracorporeal shock wave lithotripsy represents one option for the non-surgical management of Peyronie\u2019s disease. Despite promising results, several questions are still pending. We want to present the long-term results of a retrospective study using high-energy extracorporeal shock wave lithotripsy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material and methods<\/jats:title>\n                <jats:p>We evaluated retrospectively 110 patients treated between 1996 and 2020 at the Department of Urology, SLK Kliniken Heilbronn for chronic phase Peyronie\u2019s disease using two electromagnetic lithotripters (Siemens Lithostar Plus Overhead Module, Siemens Lithoskop) applying high-energy shock waves under local anesthesia and sonographic or fluoroscopic control. A standardized questionnaire focused on the change in pain, curvature, sexual function and the need of penile surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In 85 of the 110 patients (mean age 54\u00a0years) we had sufficient data for evaluation. The median follow-up was 228 (6\u2013288) months. There were no significant complications. Pain reduction was achieved in all patients, 65 (76%) patients were free of pain. Improvement of penile curvature was achieved in 43 patients (51%) ranging from 25% improvement (deflected angle\u2009&lt;\u200930\u00b0) to 95% (angle 30\u201360\u00b0). 59 patients (69%) reported problems with sexual intercourse, 40 of those (68%) reported improvement. Only 9 (10.5%) patients underwent surgical correction. We did not observe any significant differences between both electromagnetic devices with stable long-term results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>High-energy shock wave therapy delivered by two standard electromagnetic lithotripters is safe and efficient providing stable long-term results. In cases with significant plaque formation, the concept of high-energy ESWT should be considered in future studies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00345-024-04792-x","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T18:30:26Z","timestamp":1709836226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long-term experiences with high-energy shock wave therapy in the management chronic phase Peyronie\u2019s disease using two different electromagnetic lithotripters"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0436-8246","authenticated-orcid":false,"given":"Jens J.","family":"Rassweiler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Scheitlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S.","family":"Goezen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Radecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"4792_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11930-015-0045-y","volume":"7","author":"AN Bilgutay","year":"2015","unstructured":"Bilgutay AN, Pastuszak AW (2015) Peyronie\u2019s disease: a review of etiology, diagnosis, and management. Curr Sex Health Rep 7:117\u2013131","journal-title":"Curr Sex Health Rep"},{"key":"4792_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.eururo.2021.06.007","volume":"80","author":"A Salonia","year":"2021","unstructured":"Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, Cocci A, Corona G, Dimitropoulos K, G\u00fcl M, Hatzichristodoulou G, Jones TH, Kadioglu A, Mart\u00ednez Salamanca JI, Milenkovic U, Modgil V, Russo GI, Serefoglu EC, Tharakan T, Verze P, Minhas S, EAU Working Group on Male Sexual and Reproductive Health (2021) European Association of Urology Guidelines on Sexual and Reproductive Health-2021 update: male sexual dysfunction. Eur Urol 80:333\u2013357","journal-title":"Eur Urol"},{"issue":"3","key":"4792_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.5534\/wjmh.200065","volume":"39","author":"F Di Maida","year":"2021","unstructured":"Di Maida F, Cito G, Lambertini L, Valastro F, Morelli G, Mari A, Carini M, Minervini A, Cocci A (2021) The natural history of Peyronie\u2019s disease. World J Mens Health 39(3):399\u2013405","journal-title":"World J Mens Health"},{"issue":"8","key":"4792_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41443-021-00469-w","volume":"34","author":"A Cocci","year":"2022","unstructured":"Cocci A, Russo GI, Martinez-Salamanca JI, Ralph D, Djinovic R, \u015eerefo\u011flu EC, Mondaini N (2022) Is there a line between ethics and market competition? Lights and shades of the withdrawal of collagenase treatment for Peyronie\u2019s disease. Int J Impot Res 34(8):733\u2013734","journal-title":"Int J Impot Res"},{"key":"4792_CR5","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1089\/end.1999.13.549","volume":"13","author":"Y Abdel-Salam","year":"1999","unstructured":"Abdel-Salam Y, Budair Z, Renner C, Frede T, Rassweiler J, El-Annany F, El-Magraby H, El-Akkad M (1999) Treatment of Peyronie\u2019s disease by extracorporeal shockwave therapy: evaluation of our preliminary results. J Endourol 13:549\u2013552","journal-title":"J Endourol"},{"issue":"4","key":"4792_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000020013","volume":"36","author":"V Mirone","year":"1999","unstructured":"Mirone V, Imbimbo C, Palmieri A, Fusco F (1999) Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica. Eur Urol 36(4):327\u2013330. https:\/\/doi.org\/10.1159\/000020013. (PMID: 10473993)","journal-title":"Eur Urol"},{"key":"4792_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.eururo.2009.05.012","volume":"56","author":"A Palmieri","year":"2009","unstructured":"Palmieri A, Imbimbo C, Longo N, Fusco F, Verze P, Mangiapia F, Creta M, Mirone V (2009) A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie\u2019s disease. Eur Urol 56:363\u2013369","journal-title":"Eur Urol"},{"key":"4792_CR8","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/j.1464-410X.2010.09331.x","volume":"106","author":"S Chitale","year":"2010","unstructured":"Chitale S, Morsey M, Swift L, Sethia K (2010) Limited shock wave therapy vs sham treatment in men with Peyronie\u2019s disease: results of a prospective randomized controlled double-blind trial. BJU Int 106:1352\u20131356","journal-title":"BJU Int"},{"key":"4792_CR9","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1111\/jsm.12275","volume":"1","author":"G Hatzichristodoulou","year":"2013","unstructured":"Hatzichristodoulou G, Meisner C, Gschwend JE, Stenzl A, Lahme S (2013) Extracorporeal shock wave therapy in Peyronie\u2019s disease: results of a placebo-controlled, prospective, randomized, single-blind study. J Sex Med 1:2815\u20132821","journal-title":"J Sex Med"},{"key":"4792_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0090-4295(02)01527-3","volume":"59","author":"T Lebret","year":"2002","unstructured":"Lebret T, Loison G, Herv\u00e9 JM, Mc Eleny KR, Lugagne PM, Yonneau L, Orsoni JL, Saporta F, Butreau M, Botto H (2002) Extracorporeal shock wave therapy in the treatment of Peyronie\u2019s disease: experience with standard lithotriptor (siemens-multiline). Urology 59:657\u2013661","journal-title":"Urology"},{"key":"4792_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1046\/j.1442-2042.2002.00430.x","volume":"9","author":"H Kiyota","year":"2002","unstructured":"Kiyota H, Ohishi Y, Asano K, Hasegawa N, Madarame J, Miki K, Kato N, Kimura T, Ishiyama T, Maeda S, Shimomura T, Shiono Y, Miki J (2002) Extracorporeal shock wave treatment for Peyronie\u2019s disease using EDAP LT-02; preliminary results. Int J Urol 9:110\u2013113","journal-title":"Int J Urol"},{"key":"4792_CR12","first-page":"128","volume":"82","author":"E De Berardinis","year":"2010","unstructured":"De Berardinis E, Busetto GM, Antonini G, Giovannone R, Gentile V (2010) Extracorporeal shock wave therapy in the treatment of Peyronie\u2019s disease: long-term results. Arch Ital Urol Androl 82:128\u2013133","journal-title":"Arch Ital Urol Androl"},{"key":"4792_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/089277903321196788","volume":"17","author":"MS Michel","year":"2003","unstructured":"Michel MS, Ptaschnyk T, Musial A, Braun P, Lenz ST, Alken P, K\u00f6hrmann KU (2003) Objective and subjective changes in patients with Peyronie\u2019s disease after management with shock wave therapy. J Endourol 17:41\u201344","journal-title":"J Endourol"},{"key":"4792_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/sj.ijir.3901192","volume":"16","author":"RT Strebel","year":"2004","unstructured":"Strebel RT, Suter S, Sautter T, Hauri D (2004) Extracorporeal shockwave therapy for Peyronie\u2019s disease does not correct penile deformity. Int J Impot Res 16:448\u2013451","journal-title":"Int J Impot Res"},{"key":"4792_CR15","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/01.ju.0000099891.68488.4e","volume":"171","author":"EW Hauck","year":"2004","unstructured":"Hauck EW, Hauptmann A, Bschleipfer T, Schmelz HU, Altinkilic BM, Weidner W (2004) Questionable efficacy of extracorporeal shock wave therapy for Peyronie\u2019s disease: results of a prospective approach. J Urol 171:296\u2013299","journal-title":"J Urol"},{"key":"4792_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.4103\/0974-7796.192100","volume":"8","author":"RK Shimpi","year":"2016","unstructured":"Shimpi RK, Jain RJ (2016) Role of extracorporeal shock wave therapy in management of Peyronie\u2019s disease: a preliminary report. Urol Ann 8:409\u2013417","journal-title":"Urol Ann"},{"key":"4792_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.eururo.2018.01.037","volume":"74","author":"J Rassweiler","year":"2018","unstructured":"Rassweiler J (2018) Re: Extracorporeal shock wave therapy (ESWT) in Urology: a systematic review of outcome in Peyronie\u2019s disease, erectile dysfunction, and chronic pain (Words of Wisdom). Eur Urol 74:115\u2013117","journal-title":"Eur Urol"},{"key":"4792_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00345-016-1834-2","volume":"35","author":"GL Fojecki","year":"2017","unstructured":"Fojecki GL, Tiessen S, Osther PJ (2017) Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie\u2019s disease, erectile dysfunction and chronic pelvic pain. World J Urol 35:1\u20139","journal-title":"World J Urol"},{"key":"4792_CR19","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1089\/end.2006.20.880","volume":"20","author":"SJ Srirangam","year":"2006","unstructured":"Srirangam SJ, Manikandan R, Hussain J, Collins GN, O\u2019Reilly PH (2006) Long-term results of extracorporeal shockwave therapy for Peyronie\u2019s disease. J Endourol 20:880\u2013884","journal-title":"J Endourol"},{"key":"4792_CR20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41443-021-00447-2","volume":"34","author":"I Sokolakis","year":"2022","unstructured":"Sokolakis I, Pyrgidis N, Lahme S, Hatzichristodoulou G (2022) Low-intensity shockwave therapy in Peyronie\u2019s disease: long-term results from a prospective, randomized, sham-controlled trial. Int J Impot Res 34:487\u2013494","journal-title":"Int J Impot Res"},{"key":"4792_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41443-023-00673-w","author":"L Spirito","year":"2023","unstructured":"Spirito L, Manfredi C, La Rocca R, Napolitano L, Preto M, Di Girolamo A, Arcaniolo D, De Sio M, Creta M, Longo N (2023) Long-term outcomes of extracorporeal shock wave therapy for acute Peyronie\u2019s disease: a 10-year retrospective analysis. Int J Impot Res. https:\/\/doi.org\/10.1038\/s41443-023-00673-w","journal-title":"Int J Impot Res"},{"key":"4792_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/jsm.12769","volume":"12","author":"KS Coyne","year":"2015","unstructured":"Coyne KS, Currie BM, Thompson CL, Smith TM (2015) The test-retest reliability of the Peyronie\u2019s disease questionnaire. J Sex Med 12:543\u2013548","journal-title":"J Sex Med"},{"key":"4792_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1089\/end.1992.6.219","volume":"6","author":"O Seemann","year":"1992","unstructured":"Seemann O, Rassweiler J, Chvapil M, Alken P, Drach GW (1992) Effect of low dose shock wave energy on fracture healing: an experimental study. J Endourol 6:219","journal-title":"J Endourol"},{"key":"4792_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0090-4295(92)90009-L","volume":"39","author":"G Haupt","year":"1992","unstructured":"Haupt G, Haupt A, Ekkernkamp A, Gerety B, Chvapil M (1992) Influence of shock wave on wound-healing. Urology 39:529\u2013532","journal-title":"Urology"},{"key":"4792_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF00573445","volume":"115","author":"JD Rompe","year":"1996","unstructured":"Rompe JD, Hopf C, Nafe B, Burger R (1996) Low-energy extracorporeal shock wave therapy for painful heel: a prospective controlled single-blind study. Arch Orthop Trauma Surg 115:75\u201379","journal-title":"Arch Orthop Trauma Surg"},{"key":"4792_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.sxmr.2020.01.006","volume":"9","author":"H Porst","year":"2021","unstructured":"Porst H (2021) Review of the current status of low intensity extracorporeal shockwave therapy (Li-ESWT) in erectile dysfunction (ED), Peyronie\u2019s disease (PD), and sexual rehabilitation after radical prostatectomy with special focus on technical aspects of the different marketed ESWT devices including personal experiences in 350 patients. Sex Med Rev 9:93\u2013122","journal-title":"Sex Med Rev"},{"key":"4792_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/aja.aja_40_21","volume":"24","author":"M Abdessater","year":"2022","unstructured":"Abdessater M, Akakpo W, Kanbar A, Parra J, Seisen T, Chartier-Kastler E, Drouin SJ, Roupret M (2022) Low-intensity extracorporeal shock wave therapy for Peyronie\u2019s disease: a single-center experience. Asian J Androl 24:45\u201349","journal-title":"Asian J Androl"},{"key":"4792_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0302-2838(02)00225-7","volume":"42","author":"V Mirone","year":"2002","unstructured":"Mirone V, Imbimbo C, Palmieri A, Longo N, Fusco F, Tajana G (2002) A new biopsy technique to investigate Peyronie\u2019s disease associated histologic alterations: results with two different forms of therapy. Eur Urol 42:239\u2013244","journal-title":"Eur Urol"},{"key":"4792_CR29","doi-asserted-by":"publisher","first-page":"187.e1","DOI":"10.1016\/j.urology.2020.03.035","volume":"141","author":"X Zhang","year":"2020","unstructured":"Zhang X, Ruan Y, Wu AK, Zaid U, Villalta JD, Wang G, Banie L, Reed-Maldonado AB, Lin G, Lue TF (2020) Delayed treatment with low-intensity extracorporeal shock wave therapy in an irreversible rat model of stress urinary incontinence. Urology 141:187.e1-187.e7","journal-title":"Urology"},{"issue":"45","key":"4792_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.euros.2022.08.019","volume":"13","author":"JJ Rassweiler","year":"2022","unstructured":"Rassweiler JJ, Scheitlin W, Goezen AS, Rassweiler-Seyfried MC (2022) Low-energy shockwave therapy in the management of wound healing following Fournier\u2019s Gangrene. Eur Urol Open Sci 13(45):8\u201311","journal-title":"Eur Urol Open Sci"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-04792-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-024-04792-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-04792-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T21:21:59Z","timestamp":1735852919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-024-04792-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4792"],"URL":"https:\/\/doi.org\/10.1007\/s00345-024-04792-x","relation":{},"ISSN":["1433-8726"],"issn-type":[{"type":"electronic","value":"1433-8726"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"29 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JJ Rassweiler receives an honorarium from Storz-Medical, Taegerwillen, Switzerland. W Scheitlin, AS Goezen, and F Radecke have no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All patients signed an informed consent to participate in the study. The study design was presented to the Promotion Office of Medical Faculty Mannheim of the University Heidelberg, Germany and approved by the Ethical Commission (Votum 2019-696N).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and informed consent"}}],"article-number":"124"}}